Nucleosomes are barriers to RNA Polymerase II (Pol II) transcribing along gene bodies in eukaryotes. We found that a fragile “tailless nucleosome” could be generated to resolve the Pol II pausing ...
The Magnificent Seven represent 34.4% of the S&P 500 as of January 2026, up from 12.5% in 2016. From 2016 through 2025, these seven companies achieved an 870.1% return, outperforming the S&P 500. The ...
Thermo Fisher Scientific’s Accelerator Drug Development is a suite of integrated services combining CDMO and CRO capabilities to streamline the drug development journey, from early-stage research to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback